Low Risk | Side Effects Guide

Hyoscine Hydrobromide Side Effects

Side effects of Hyoscine Hydrobromide (TRAVACALM H.O. Chewable hyoscine hydrobromide 300 micrograms tablet strip pack) that impact work capacity, driving, and recovery for claims professionals, support workers, and care managers. Also known as TRAVACALM H.O. Chewable hyoscine hydrobromide 300 micrograms tablet strip pack, KWELLS hyoscine hydrobromide 0.3mg chewable tablet blister pack (new formulation), KWELLS KIDS hyoscine hydrobromide 0.15mg chewable tablet blister pack.

Source: TGA Updated April 2026

Hyoscine Hydrobromide (TRAVACALM H.O. Chewable hyoscine hydrobromide 300 micrograms tablet strip pack) is classified as Low risk by AllMeds. It is a CNS depressant that can cause drowsiness, impaired coordination, and reduced cognitive function, directly affecting work capacity and return-to-work timelines. For claims professionals, the side effects of Hyoscine Hydrobromide can impact work capacity, driving fitness, and recovery timelines.

Key Takeaways

  • Risk level: Low (2 points)
  • CNS depressant: Causes sedation, impairs driving, affects cognitive function
  • Duration limit: 7 days recommended maximum
  • Claims action: Assess work capacity impact, check for dangerous interactions, review duration against guidelines

Side Effects That Affect Work Capacity

These side effects of Hyoscine Hydrobromide can directly impact a claimant's ability to work, drive, and perform daily activities:

  • Drowsiness and sedation
  • Impaired concentration and cognitive function
  • Slowed reaction time
  • Impaired coordination and balance
  • Nausea and constipation

Work capacity certificates should reflect any medication-related restrictions. For safety-sensitive roles (driving, operating machinery, working at heights), these effects may require modified duties or temporary stand-down.

Dependency and Withdrawal

Hyoscine Hydrobromide carries a risk of physical dependence with regular use. This is a common complicating factor in injury claims:

  • Physical dependence with regular use
  • Tolerance requiring dose escalation
  • Withdrawal symptoms on cessation

Flags for Claims Professionals

  • CNS depressant effects may delay return to work, particularly in safety-sensitive roles
  • Opioid dependency risk increases with duration beyond guidelines
  • Recommended maximum duration: 7 days

Need to assess this medication across your caseload?

Run a full risk assessment to check Hyoscine Hydrobromide side effects, interactions, and compliance across the full medication list.

AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.

No credit card required. No signup for your first 2 questions.

Related Resources

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.